Skip to main content

Table 3 Adverse events reported in this study

From: Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation

  Telbivudine Control P value
CK Elevation of mother, n (%) 7 (5%) 0 (0%) 0.022
Malformation induced labor, n 1 1 1.000
Abortion, n 1 2 0.575
Premature labor, n 3 2 1.000
Congenital diseases, n 1 1 1.000